期刊文献+

全腔静脉肺动脉连接术后早期吸入一氧化氮对肺血管阻力的影响 被引量:1

The effects of inhaled nitric oxide on pulmonary vascular resistance in patients after total cavopulmonary connection
原文传递
导出
摘要 目的探讨吸入一氧化氮(NO)对全腔静脉肺动脉连接(TCPC)术后早期肺血管阻力的影响。方法24例术后早期通过呼吸机吸入NO的TCPC患者为实验组,吸入前后计算心排出量及肺血管阻力;28例未吸入NO的TCPC患者为对照组。比较两组呼吸机辅助时间、ICU滞留时间、胸腔引流管留置时间及住院时间。结果实验组吸入NO后同吸入前比较氧合指数从161±17升高至193±23(t=2.75,P<0.01);心脏指数从(2.86±0.24)L·min-1·m-2增加至(3.13±0.22)L·min-1·m-2(t=2.25,P<0.05);肺血管阻力从(4.2±0.5)U/m2下降至(3.8±1.4)U/m2(t=2.29,P<0.05);中心静脉压从(17.0±1.8)mmHg(1mmHg=0.133kPa)降至(15.0±1.1)mmHg,下降11.7%。与对照组相比,呼吸机辅助时间从(86±27)h缩短为(54±18)h(t=2.29,P<0.05);ICU居留时间从(6±2)d缩短至(4±2)d(t=2.32,P<0.05);胸腔引流管留置时间及住院时间差异无统计学意义。结论吸入NO对TCPC术后远期疗效虽无明显影响,但有助于避免术后早期肺血管阻力一过性升高所致的低心排出量综合征及腔静脉高压,NO是安全、有效的肺血管扩张剂。 Objective To study the effects of inhaled nitric oxide (NO) on pulmonary vascular resistance in patients after total cavopulmonary connection (TCPC). Methods Fifty-two patients after TCPC were evaluated,of them 24 patients were administered with inhaled nitric oxide in the early postoperative period.The cardiac index (CI) and pulmonary vascular resistance (PVR) were compared before and after inhaled NO. Results In experimental group, after inhaled NO, partial pressure of oxygen in artery/fraction of inspired oxygen increased from 161±17 to 193±23 (t=2.75,P<0.01);CI from (2.86±0.24)L·min^(-1)·m^(-2) to (3.13±0.22)L·min^(-1)·m^(-2) (t=2.25,P<0.05);PVR decreased from (4.2±0.5) U/m^2 to (3.8±1.4)U/m^2 (t=2.29,P<0.05);central venous pressure (CVP) from (17.0±1.8)mm Hg to(15.0±1.1)mm Hg,decreased 11.7%. Compared with the control group,respirator time decreased from (86±27)h to (54±18)h (t=2.29,P<0.05);ICU time from (6±2)d to((4±2)d )(t=2.32,P<0.05);But hydrothorax drainage and length of stay had no significant difference.(Conclusions Though inhaled) NO, there is no significant long-term effects in patients after TCPC, but it may play an important role in the management of low cardiac output syndrome and high cava pressure caused by reactive elevated pulmonary vascular resistance in the early postoperative period of TCPC.
出处 《中华外科杂志》 CAS CSCD 北大核心 2005年第10期647-649,共3页 Chinese Journal of Surgery
基金 全军医药卫生科研基金资助项目(98D001)
  • 相关文献

参考文献8

  • 1Maxey TS, Smith CD, Kern JA, et al. Beneficial effects of inhaled nitric oxide in adult cardiac surgical patients. Ann Thorac Surg,2002,73 : 529-533.
  • 2De Leval MR, Kilner P, Gewillig M, et al. Total cavopuomonary connection: a logical alternative to atriopulmonary connection for complex Fontan operation: experimental studie and early clinical experience. J Thorac Cardiovasc Surg. 1988.96:682-695.
  • 3Choussat A, Fontan F,Besse P,et al.Selection criteria for Fontan's procedure. In: Anderson RH, Shinebourne EA, eds. Pediatric cardiology. Edinburgh : Churchill Livingstone, 1978. 559-563.
  • 4Steudel W,Hurford WE,Zapol WM.Inhaled nitric oxide: basic biology and clinical applications.Anesthesiology,1999,91:1090-1121.
  • 5Chai PJ, Williamson JA, Lodge A J, et al. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass. Ann Thorac Surg. 1999.67:731-735.
  • 6尹宗涛,张仁福,王军,高文根.全腔静脉肺动脉连接手术对降钙素基因相关肽分泌的影响[J].中华外科杂志,2002,40(9):679-681. 被引量:3
  • 7尹宗涛,张仁福,王军,高文根.全腔静脉肺动脉连接术后内皮素分泌的随访研究[J].中华胸心血管外科杂志,2002,18(4):196-198. 被引量:5
  • 8Miyaji K, Nagata N, Miyamoto T, et al.Combined therapy with inhaled nitric oxide and intravenous epoprostenol ( prostacyclin ) for critical pulmonary perfusion after the Fontan procedure. J Thorac Cardiovasc Surg,2003,125:437-439.

二级参考文献9

  • 1Champion HC,Bivalacqua TJ,Toyoda K,et al.In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse[].Circulation.2000
  • 2Kusakabe T,Kawakami T,Powell FL,et al.Distribution of substance P and calcitonin gene-related peptide immunoreactivity nerve fibers in the trachea of chronically hypoxic rats[].Brain Research Bulletin.1996
  • 3Keith IM,Ekman R.Dynamic aspects of regulatory lung peptides in chronic hypoxia pulmonary hypertion[].Experimental Lung Research.1992
  • 4Domkowski PW,Cockerham JT,Kot PA,et al.Characterization of the pulmonary arterial response to endothelin-1 and bosentan in neonatal pigs[].The Annals of Thoracic Surgery.2000
  • 5Yoshibayashi M,Nishioka K,Nakao K,et al.Plsama endothlin concentrations in patients with pulmonary hypertension associated with congenital heart defects.Evidence for increased production of endothlin in pulmonary circulation[].Circulation.1991
  • 6Amodeo A,Galletti L,Marianeschi S,et al.Extracardiac Fontan operation for complex cardiac anomalies: seven years’experience[].Journal of Thoracic and Cardiovascular Surgery.1997
  • 7Russell FD,Molenaar P.The human heart endothelin system: ET-1 synthesis, storage, release and effect[].Trends in Pharmacological Sciences.2000
  • 8Haynes WG,Webb DJ.The endothelin family of peptides: local hormones with diverse roles in health and disease[].Clinical Science.1993
  • 9Vincent JA,Ross RD,Kassab J,et al.Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow[].The American Journal of Cardiology.1993

共引文献4

同被引文献26

  • 1Hildebrand M, Krause W, Fabian H, et al. Pharmacoki- netics of iloprost in patients with chronic renal failure and on maintenance haemodialysis [ J ]. Int J Clin Pharmacol Res, 1990,10 ( 5 ) : 285 -292.
  • 2Schermuly R T, Schulz A, Ghofrani H A, et al. Pharma- cokinetics and metabolism of infused versus inhaled ilo- prost in isolated rabbit lungs [ J ]. J Pharmacol Exp Ther, 2002,303 ( 2 ) :741-745.
  • 3Fontan F, Baudet E. Surgical repair of tricuspid atresia [ J ]. Thorax, 1971,26 ( 3 ) : 240-248.
  • 4de Leval M R, Kilner P, Gewillig M, et al. Total cavop- ulmonary connection: a logical alternative to atriopulmo- nary connection for complex Fontan operations. Experi- mental studies and early clinical experience [ J ]. J ThoracCardiovase Surg, 1988,96(5 ) :682-695.
  • 5Yun T J, Rho J R. Aprotinin attenuates the elevation of pulmonary vascular resistance after cardiopulmonary by- pass[ J]. J Korean Med Sci, 2006,21 ( 1 ) :25-29.
  • 6Khairy P, Fernandes S M, Mayer J E Jr, et al. Long- term survival, modes of death, and predictors of mortality in patients with Fontan surgery [ J]. Circulation, 2008, 117(1) :85-92.
  • 7Barst IR J, Rubin L J, Long W A, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group [ J]. N Engl J Med, 1996,334(5) :296-302.
  • 8Galie N, Ghofrani H A, Torbicki A, et al. Sildenafil cit- rate therapy for pulmonary arterial hypertension [ J ]. N Engl J Med, 2005,353(20) :2148-2157.
  • 9Rubin L J, Badesch D B, Barst R J, et al. Bosentan therapy for pulmonary arterial hypertension [ J ]. N Engl J Med, 2002,346(12) :896-903.
  • 10Simonneau G, Barst R J, Galie N, et al. Continuous subcutaneous infusion of treprostinil, a prostaeyelin ana- logue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial [ J ]. Am J Respir Crit Care Med, 2002,165 (6) :800-804.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部